Follow the 강스템바이오텍 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 강스템바이오텍 has recorded 97 insider filings. Market capitalisation: €206bn. The latest transaction was disclosed on 12 March 2026 (Other). Among the most active insiders: 나종천. The full history is free.
97
Insider Decl.
n/a
Thresholds
n/a
8 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,681 of 29,064 companies
19.9
score / 100
Value
21
Quality
19
FCF yld-6.0%
Earn yld-5.1%
EV/EBITDA·
ROE-48%
Gross mgn24%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.